Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

NF-κB

Items 131-140 of 154

Page
per page
  1. JSH-23
    B1645 JSH-23
     7 Citation
    Summary: NF-κB inhibitor
      ≥24 mg/mL
  2. Sodium 4-Aminosalicylate
    B1643 Sodium 4-Aminosalicylate
    Summary: NF-κB inhibitor
      ≥10.65 mg/mL
  3. Strontium Ranelate
    A8526 Strontium Ranelate
    Summary: Calcium Channel activator
      insoluble in EtOH; insoluble in DMSO; ≥2.57 mg/mL
  4. QNZ (EVP4593)
    A4217 QNZ (EVP4593)
     6 Citation
    Summary: Potent NF-κB inhibitor
  5. Triptolide
    A3891 Triptolide
     6 Citation
    Summary: IL-2/MMP-3/MMP7/MMP19 inhibitor
      ≥36 mg/mL
  6. Emodin
    A3392 Emodin
    Target: CK2
    Summary: Naturally occurring anthraquinone,antiproliferative
      ≥27 mg/mL
  7. Naringin Dihydrochalcone
    C6447 Naringin Dihydrochalcone
    Summary: A dihydrochalcone artificial sweetener derived from naringin
      insoluble in H2O; ≥87.5 mg/mL
  8. Schizandrin B
    N1656 Schizandrin B
    Target: Nrf2|ROS and Other Gaseous Donors
    Summary: inhibits lipid peroxidation
      insoluble in EtOH; insoluble in H2O; ≥20 mg/mL
  9. Gallic acid
    N1830 Gallic acid
    Target: Antioxidants
    Summary: A natural polyphenolic compound with antioxidant, anti-inflammatory, antibacterial, and antitumor activities.
      insoluble in H2O; ≥5.95 mg/mL
  10. Quinoclamine
    C6927 Quinoclamine
    Summary: A naphthoquinone derivative with antitumor and NF-κB pathway inhibitory activity
      ≥38.7 mg/mL

Items 131-140 of 154

Page
per page